Trends in net survival from cervical cancer in a Brazilian state with medium Human Development Index
- PMID: 40646170
- PMCID: PMC12254479
- DOI: 10.1038/s41598-025-10659-x
Trends in net survival from cervical cancer in a Brazilian state with medium Human Development Index
Abstract
Cervical cancer remains a major public health concern in Northeast Brazil, ranking as the second most common cancer among women. This study provides the first long-term, population-based estimates of net survival from cervical cancer in Sergipe, a Brazilian state with a medium Human Development Index, using high-quality registry data subjected to rigorous quality control procedures. We analysed data for 3,977 women aged 15-99 years diagnosed with an invasive cervical cancer between 1996 and 2017 and followed up to 2022, after excluding 6,095 in situ neoplasms. Net survival was estimated using the Pohar Perme method, stratified by histological subtype and calendar period, and age-standardised with the International Cancer Survival Standard weights. We observed a substantial decline in survival over time: one-year net survival dropped from 84.6% (1996-1999) to 73.4% (2015-2017), and five-year survival from 60.8 to 49.3%. Squamous cell carcinoma and adenocarcinoma showed similar survival patterns, with five-year survival ranging from 55 to 58%. The persistent decline in net survival may reflect a shift toward more advanced or aggressive invasive cancers, as screening programmes increasingly detect and remove early-stage lesions. Delayed diagnosis and sub-optimal treatment further contribute, underscoring the need to improve screening and timely cancer care access.
Keywords: Brazil; Cervical cancer; Epidemiology; Histology; Population-based survival.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval: This study was approved by the Research Ethics Committee of the Federal University of Sergipe (Reference 3.714.982) and was conducted in compliance with all applicable ethical guidelines and regulations. Consent to participate: As the data used in this study were anonymised and accessed through secondary sources, informed consent was waived for participants, in accordance with Brazilian Ministry of Health Resolution 466/2012.
Figures


Similar articles
-
Temporal trends in the relative survival among women with cervical cancer in Canada: a population-based study.Int J Gynecol Cancer. 2012 Sep;22(7):1208-13. doi: 10.1097/IGC.0b013e318263f014. Int J Gynecol Cancer. 2012. PMID: 22854653
-
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.Cochrane Database Syst Rev. 2015 Apr 7;(4):CD010260. doi: 10.1002/14651858.CD010260.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Aug 22;8:CD010260. doi: 10.1002/14651858.CD010260.pub3. PMID: 25847525 Updated.
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Psychological therapies for women who experience intimate partner violence.Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD013017. doi: 10.1002/14651858.CD013017.pub2. Cochrane Database Syst Rev. 2020. PMID: 32608505 Free PMC article.
References
-
- Ferlay, J. et al. Global Cancer Observatory: Cancer Today 2022. https://gco.iarc.who.int/today (2024).
-
- Waggoner, S. E. Cervical cancer. Lancet361, 2217–2225 (2003). - PubMed
-
- Galic, V. et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol. Oncol.125, 287–291 (2012). - PubMed
-
- INCA. Estimativa 2023: Incidência De Câncer No Brasil (Instituto Nacional De Câncer, 2023).